Prosecution Insights
Prosecution Insights
1 pending office actions • 0 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Université De Fribourg currently has 1 pending office action being managed by 1 distinct examiner. The data indicates that there are 0 distinct art units associated with this prosecution activity. The busiest examiner for this portfolio is SKIBINSKY, ANNA, who is responsible for 1 pending office action.
With only 1 distinct examiner involved, the company's current prosecution efforts are highly centralized. SKIBINSKY, ANNA represents the entire pending workload for the company. This streamlined profile, featuring the pending action and 0 distinct art units, requires a focused approach to the specific requirements of the assigned examiner.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SKIBINSKY, ANNA | 1 | 39.0% | +29.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18271066 | BIOMARKERS FOR BREAST CANCER DETECTION | SKIBINSKY, ANNA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18271066 | BIOMARKERS FOR BREAST CANCER DETECTION | SKIBINSKY, ANNA | — |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18271066 | BIOMARKERS FOR BREAST CANCER DETECTION | SKIBINSKY, ANNA | — | §101§103§112 | Non-Final OA | — | Pending | Jul 06, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial